Australian Life Scientist
June 1, 2004 by admin
Filed under Media Reports, Media Reports 2004
| Trials without error: Australia’s clinical capabilities Australia’s clinical trial expertise may be the great undiscovered bargain for pharmas and biotechs from both the east and the western world. That sentiment comes from at least one high-profile international biotech observer — Richard Haiduck, a director of biotech investment bank Burrill & Co, confided as much to a recent gathering at the Securities Institute in New South Wales. |
For a licensed copy [CAL] of this article please email us at: team{at}onlinemediarooms.com Quote #1001 ![]() |









